Biotechnology company Cebiotex, a CataloniaBio member, has raised €1.8 million after launching its second round of social-impact funding. Investors included Ship2B, Inveready, family offices and others from two crowdfunding campaigns. These funds will allow the spin-off of Hospital Sant Joan de Déu Barcelona and the Polytechnic University of Catalonia to transfer its antitumor therapies to paediatrics and finish the preclinical phase with CEB-01, a local post-op oncology treatment for soft-tissue sarcomas.

Photo: Joan Bertran, co-founder and CEO of Cebiotex. © PCB.